 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 8 | 1/1 | 返回列表 |
| 查看: 1474 | 回復(fù): 7 | |||
luwangxing金蟲 (正式寫手)
|
[交流]
【轉(zhuǎn)帖】國(guó)產(chǎn)PVP遭遇FDA發(fā)難，過氧化物超標(biāo) 已有5人參與
|
|
原文：http://www.fda.gov/drugs/drugsafety/ucm230492.htm 博愛新開源算是國(guó)內(nèi)PVP較為主要的供應(yīng)商吧 過氧化物超標(biāo)4倍 CP05，和CP10沒有檢查該項(xiàng)目 Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone [10-21-2010] The U.S. Food and Drug Administration is alerting drug and dietary supplement manufacturers, compounding pharmacies, and distributors of Povidone analogs (Povidone/Copovidone/Crospovidone), that the agency recently detected excessive levels of peroxide in one lot of Crospovidone (cross linked polyvinyl N-pyrrolidone) manufactured by China-based Tianjin Boai NKY International Ltd1. The peroxide level found by the FDA in the lot was more than four (4) times the maximum level of peroxide (400 ppm) allowed by global compendial monographs. Other lots of Povidone analogs2 manufactured by this firm may also contain excessive levels of peroxide. An Import Alert has been issued to prevent further entry of Tianjin Boai NKY International Ltd Crospovidone into the U.S. market. To date, the FDA is not aware of any illnesses in the United States stemming from peroxide contamination. The level of peroxide found in this particular lot does not appear, on its own, to pose a significant health risk in drugs or dietary supplements. The FDA nonetheless remains concerned that elevated levels of peroxide can cause subpotent finished products. Crospovidone is a very common ingredient in drugs and dietary supplements. Peroxide is a potential impurity from the polymerization step involved in the manufacturing of Povidone analogs. Residual peroxide levels of <100 ppm have been reported to cause oxidative degradation.3 The FDA is concerned that drug manufacturers using excipients containing high levels of peroxides will observe a loss of drug potency and the formation of excessive impurities during the product shelf life. It is essential that users and distributors implement robust supplier management programs to assure that peroxide levels in Povidone analogs are in control for each batch received. Manufacturers using such excipients should employ sound risk management principles in establishing appropriate scrutiny (including peroxide testing regimen) and actions to take for a given supplier, including but not limited to the following: ( a ) review supplier history, including any relevant information on manufacturing reliability; ( b ) assess peroxide levels obtained from testing4 of past batches of Povidone analogs; ( c ) determine reliability of results reported on Certificates of Analysis; ( d ) consider information obtained from ongoing communications with suppliers; and ( e ) determine whether the quality of any finished product has been impacted. Manufacturers who use ingredients that might contain elevated levels of peroxide are advised to notify the FDA if they become aware of any further findings of quality problems or potentially related adverse events. 1 May also do business as Friends Union Enterprise (Jianjin) Ltd, Boai New Kaiyuan Pharmaceutical Company, Boai NKY Pharmaceuticals Ltd or Bluetech Chemicals Limited. 2 A recently published study also found elevated levels of peroxide in multiple lots of Povidone analogs, consistent with the FDA’s findings. (Silverstein, PhD, Irwin, Pharmaceutical Technology, Vol. 33, Issue 10, pp. 84-88, October 02, 2009. “The Case for Supplier Qualification.”) 3 Hartauer, et al, Pharm. Dev. Technol. 2000;5(3):303-10. “Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product.” 4 A peroxide test is not currently listed in the USP monographs for crospovidone and povidone. However, a non-specific USP/EP method (see Copovidone NF) can be used to readily detect peroxide present at 400 ppm in Povidone analogs. Alternatively, a validated method shown to be specific for peroxide and having at least the same sensitivity as the compendial method may be used. For import alert information, please see: http://www.accessdata.fda.gov/cms_ia/importalert_189.html 這是我在sfda網(wǎng)站看到的。據(jù)我所知，巴斯夫的交聯(lián)吡咯烷酮的COA中有這一項(xiàng)指標(biāo)，標(biāo)準(zhǔn)是不大于400ppm。 |
回復(fù)此樓» 猜你喜歡
焦慮
已經(jīng)有10人回復(fù)
-
298-一志愿中國(guó)農(nóng)業(yè)大學(xué)-求調(diào)劑
已經(jīng)有3人回復(fù)
-
265求調(diào)劑
已經(jīng)有3人回復(fù)
-
297求調(diào)劑
已經(jīng)有3人回復(fù)
-
302求調(diào)劑
已經(jīng)有8人回復(fù)
-
環(huán)境工程調(diào)劑
已經(jīng)有7人回復(fù)
-
268求調(diào)劑
已經(jīng)有6人回復(fù)
-
311求調(diào)劑
已經(jīng)有11人回復(fù)
-
工科材料085601 279求調(diào)劑
已經(jīng)有4人回復(fù)
-
301求調(diào)劑
已經(jīng)有9人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 轉(zhuǎn)：具有全新降低血糖機(jī)制的新藥被fda專家小組否定
已經(jīng)有3人回復(fù)
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時(shí)
- 蟲號(hào): 338983
- 注冊(cè): 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
2樓2010-10-26 10:31:59
reallove2935
禁言 (著名寫手)
★
小木蟲(金幣+0.5):給個(gè)紅包，謝謝回帖交流
小木蟲(金幣+0.5):給個(gè)紅包，謝謝回帖交流
|
本帖內(nèi)容被屏蔽 |
3樓2010-10-26 14:03:00
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時(shí)
- 蟲號(hào): 338983
- 注冊(cè): 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
4樓2010-10-26 15:04:13
5樓2010-10-26 16:26:16
reallove2935
禁言 (著名寫手)
|
本帖內(nèi)容被屏蔽 |
6樓2010-10-28 09:01:32
meteord
木蟲 (正式寫手)
- 應(yīng)助: 17 (小學(xué)生)
- 金幣: 5330.2
- 散金: 68
- 紅花: 1
- 帖子: 436
- 在線: 192.9小時(shí)
- 蟲號(hào): 862641
- 注冊(cè): 2009-10-04
- 性別: GG
- 專業(yè): 藥劑學(xué)
7樓2010-10-28 09:15:57
zblyyk
金蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1216.1
- 帖子: 246
- 在線: 54小時(shí)
- 蟲號(hào): 921166
- 注冊(cè): 2009-12-06
- 性別: GG
- 專業(yè): 藥劑學(xué)
8樓2010-11-06 14:39:38
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 luwangxing 的主題更新
| 8 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 268求調(diào)劑 +6 | 簡(jiǎn)單點(diǎn)0 2026-03-17 | 6/300 |
|
|---|---|---|---|---|
|
|
[考研] 341求調(diào)劑 +5 | 搗蛋豬豬 2026-03-11 | 7/350 |
|
|
|
[考研] 301求調(diào)劑 +4 | A_JiXing 2026-03-16 | 4/200 |
|
|
|
[考研] 302求調(diào)劑 +9 | 負(fù)心者當(dāng)誅 2026-03-11 | 9/450 |
|
|
|
[考研] 293求調(diào)劑 +6 | 世界首富 2026-03-11 | 6/300 |
|
|
|
[考研] 一志愿蘇州大學(xué)材料工程（085601）專碩有科研經(jīng)歷三項(xiàng)國(guó)獎(jiǎng)兩個(gè)實(shí)用型專利一項(xiàng)省級(jí)立項(xiàng) +6 | 大火山小火山 2026-03-16 | 8/400 |
|
|
[考研] 材料與化工專碩調(diào)劑 +5 | heming3743 2026-03-16 | 5/250 |
|
|
|
[論文投稿] 有沒有大佬發(fā)小論文能帶我個(gè)二作 +3 | 增銳漏人 2026-03-17 | 4/200 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +6 | 妮妮ninicgb 2026-03-15 | 9/450 |
|
|
|
[考研] 070303一志愿西北大學(xué)學(xué)碩310找調(diào)劑 +5 | d如愿上岸 2026-03-12 | 8/400 |
|
|
|
[考研] 一志愿華中師范071000，325求調(diào)劑 +6 | RuitingC 2026-03-12 | 6/300 |
|
|
|
[考博] 東華理工大學(xué)化材專業(yè)26屆碩士博士申請(qǐng) +6 | zlingli 2026-03-13 | 6/300 |
|
|
|
[考研] 265求調(diào)劑 +4 | 威化餅07 2026-03-12 | 4/200 |
|
|
|
[考研] 330求調(diào)劑 +3 | ?醬給調(diào)劑跪了 2026-03-13 | 3/150 |
|
|
|
[考研] 311求調(diào)劑 +3 | 冬十三 2026-03-13 | 3/150 |
|
|
|
[考研] 工科調(diào)劑 +4 | Jiang191123！ 2026-03-11 | 4/200 |
|
|
|
[考研] 一志愿山大07化學(xué) 332分 四六級(jí)已過 本科山東雙非 求調(diào)劑！ +3 | 不想理你 2026-03-12 | 3/150 |
|
|
|
[考研] 0856化學(xué)工程280分求調(diào)劑 +4 | shenzxsn 2026-03-11 | 4/200 |
|
|
|
[考研] 321求調(diào)劑（食品/專碩） +3 | xc321 2026-03-12 | 6/300 |
|
|
|
[考研] 333求調(diào)劑 +3 | 152697 2026-03-12 | 4/200 |
|